These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15738002)

  • 1. Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate.
    Cieslik KA; Zhu Y; Shtivelband M; Wu KK
    J Biol Chem; 2005 May; 280(18):18411-7. PubMed ID: 15738002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription-based COX-2 inhibition: a therapeutic strategy.
    Wu KK
    Thromb Haemost; 2006 Oct; 96(4):417-22. PubMed ID: 17003917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway.
    Cieslik K; Zhu Y; Wu KK
    J Biol Chem; 2002 Dec; 277(51):49304-10. PubMed ID: 12379662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts.
    Saunders MA; Sansores-Garcia L; Gilroy DW; Wu KK
    J Biol Chem; 2001 Jun; 276(22):18897-904. PubMed ID: 11278846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells.
    Lin CH; Nai PL; Bien MY; Yu CC; Chen BC
    J Immunol; 2014 Jan; 192(1):338-48. PubMed ID: 24277696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases.
    Petrella BL; Armstrong DA; Vincenti MP
    J Cell Physiol; 2011 Dec; 226(12):3349-54. PubMed ID: 21344389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
    Wu KK
    Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Control of COX-2 via C/EBPbeta.
    Wu KK; Liou JY; Cieslik K
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):679-85. PubMed ID: 15681294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages.
    Cho YH; Lee CH; Kim SG
    Mol Pharmacol; 2003 Mar; 63(3):512-23. PubMed ID: 12606757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity.
    Lee S; Shuman JD; Guszczynski T; Sakchaisri K; Sebastian T; Copeland TD; Miller M; Cohen MS; Taunton J; Smart RC; Xiao Z; Yu LR; Veenstra TD; Johnson PF
    Mol Cell Biol; 2010 Jun; 30(11):2621-35. PubMed ID: 20351173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of COX-2 and iNOS gene expressions by aspirin and salicylate.
    Wu KK
    Thromb Res; 2003 Jun; 110(5-6):273-6. PubMed ID: 14592547
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3.
    Zhao X; Zhuang S; Chen Y; Boss GR; Pilz RB
    J Biol Chem; 2005 Sep; 280(38):32683-92. PubMed ID: 16055922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor.
    Hanlon M; Sturgill TW; Sealy L
    J Biol Chem; 2001 Oct; 276(42):38449-56. PubMed ID: 11500490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-dependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I gene.
    Umayahara Y; Kajimoto Y; Fujitani Y; Gorogawa S; Yasuda T; Kuroda A; Ohtoshi K; Yoshida S; Kawamori D; Yamasaki Y; Hori M
    J Biol Chem; 2002 May; 277(18):15261-70. PubMed ID: 11825899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice.
    Buck M; Chojkier M
    PLoS One; 2011; 6(10):e25497. PubMed ID: 21998664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
    Reipas KM; Law JH; Couto N; Islam S; Li Y; Li H; Cherkasov A; Jung K; Cheema AS; Jones SJ; Hassell JA; Dunn SE
    Oncotarget; 2013 Feb; 4(2):329-45. PubMed ID: 23593654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and salicylate: An old remedy with a new twist.
    Wu KK
    Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
    [No Abstract]   [Full Text] [Related]  

  • 20. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts.
    Gorgoni B; Caivano M; Arizmendi C; Poli V
    J Biol Chem; 2001 Nov; 276(44):40769-77. PubMed ID: 11522796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.